1. Home
  2. ALLO vs BRT Comparison

ALLO vs BRT Comparison

Compare ALLO & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.69

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo BRT Apartments Corp. (MD)

BRT

BRT Apartments Corp. (MD)

HOLD

Current Price

$14.66

Market Cap

285.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
BRT
Founded
2017
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
285.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
BRT
Price
$1.69
$14.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
2
Target Price
$8.27
$19.75
AVG Volume (30 Days)
7.1M
35.4K
Earning Date
03-12-2026
03-11-2026
Dividend Yield
N/A
6.77%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$98,001,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.30
52 Week Low
$0.86
$14.00
52 Week High
$3.78
$19.01

Technical Indicators

Market Signals
Indicator
ALLO
BRT
Relative Strength Index (RSI) 52.72 47.15
Support Level $1.62 $14.51
Resistance Level $1.97 $14.81
Average True Range (ATR) 0.16 0.29
MACD -0.00 -0.01
Stochastic Oscillator 42.72 38.45

Price Performance

Historical Comparison
ALLO
BRT

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About BRT BRT Apartments Corp. (MD)

BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.

Share on Social Networks: